Transcription of PMDAホームページ システムメンテナンスのお知らせ | 独立行政 …
{{id}} {{{paragraph}}}
JP XVIITHE JAPANESE PHARMACOPOEIASEVENTEENTH EDITIONO fficial from April 1, 2016 English VersionTHE MINISTRY OF HEALTH, LABOUR AND WELFAREN otice: ThisEnglish Versionof the Japanese Pharmacopoeia is publishedfor the convenience of users unfamiliar with the Japanese language. Whenand if any discrepancy arises between the Japanese original and its Englishtranslation, the former is Ministry of Health, Labour andWelfare Ministerial Notification No. 64 Pursuant to Paragraph 1, Article 41 of theLaw on Securing Quality, Efficacy andSafety of Products including Pharmaceuticals and Medical Devices (Law No. 145,1960), the Japanese Pharmacopoeia (Ministerial Notification No. 65, 2011), whichhas been established as follows*, shall be applied on April 1, 2016. However, in thecase of drugs which are listed in the Pharmacopoeia (hereinafter referred to as ``previ-ous Pharmacopoeia'') [limited to those listed in the Japanese Pharmacopoeia whosestandards are changed in accordance with this notification (hereinafter referred to as``new Pharmacopoeia'')] and have been approved as of April 1, 2016 as prescribedunder Paragraph 1, Article 14 of the same law [including dru]
We are currently performing system maintenance. As a result, the website is temporarily out of service. We apologize for the inconvenience, and we appreciate your patience and understanding.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
537 determination of selected perfluorinated alkyl, Liquid Chromatography, Mass spectrometry, Determination of pesticide residues in, Liquid, Chromatography, EURL-FV, Mass, Waters Acquity Ultra-Performance Liquid, Waters Acquity Ultra-Performance Liquid Chromatograph, Purity Analysis and Impurities Determination by, Analysis and Impurities Determination by, Application, Insulinum humanum